Why GLP-1 & GIP Medications Are Changing Lives
GLP-1 and GIP medications offer powerful health improvements beyond weight loss
even if Medicare limits weight-loss-only coverage.
Key Health Benefits:
- Improved blood sugar control
- Reduced blood pressure
- Lower inflammation & cardiovascular risk
- Significant, clinically proven weight loss
- Reduced appetite & cravings
- Strong metabolic & longevity support
For patients with diabetes or cardiovascular risk factors, GLP-1 & GIP
medications may be medically indicated and Medicare-covered.
Why Medicare Patients
Choose Leadwest Medical
100% Telehealth - No Clinic Visits Needed
Receive complete care from home with:
- No transportation needs
- No long wait times
- Easy scheduling
- Direct access to licensed clinicians
Medicare covers telehealth E/M visits through September 2025 (and likely beyond).
We Handle All Medicare Eligibility & Coverage Checks
No more calling insurance or sitting on hold, we handle everything:
- Plan formulary checks
- Diagnosis eligibility
- Prior authorizations
- Alternative coverage pathways
- Out-of-pocket estimates
You only proceed when you clearly understand your coverage.
Safe, Experienced Medical Providers
Our clinicians specialize in:
- GLP-1 & GIP medication use
- Metabolic health
- Diabetes management
- Cardiovascular screening
- Medication interactions
- Safe titration & follow-up
You get a full medical assessment, not a fast online prescription.
Medication Management Made Simple
If you’re eligible for Medicare coverage, we manage:
- Diagnostic documentation
- Medical necessity proof
- Lab orders
- Prior authorization steps
- Pharmacy coordination
You simply attend your telehealth visit – we handle the rest.
How the Process Works
Complete Your Intake
Fill out a quick online questionnaire to share your health and Medicare details.
Meet With Your Provider
Join a telehealth visit for a full medical evaluation and Medicare coverage review.
Receive Your Medication
If approved, receive your GLP-1 or GIP prescription through Medicare or an affordable alternative.
Who Qualifies for
Medicare-Covered GLP-1 & GIP?
You may qualify if you have:
- Type 2 diabetes
- High cardiovascular risk
- Obesity with diabetes-related conditions
- Other FDA-approved medical indications
Our experience can help with approval. Our intake determines your eligibility before any commitment. Medicare does NOT cover GLP-1 or GIP medications for weight-loss-only purposes.
What Makes Leadwest Different?
Leadwest is designed for clarity, safety, and simplicity – especially
for Medicare patients.
- Transparent Medicare coverage checks
- GLP-1 & GIP–experienced clinicians
- Fast telehealth scheduling
- Simple patient portal
- Optional cash-pay alternatives
- Discreet medication shipping
GLP-1 & GIP Insights
Testimonials
What Clients Are Saying
See For Yourself
Weight Loss FAQs
Semaglutide is a prescription medication used to treat type 2 diabetes and obesity. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the action of the naturally occurring hormone GLP-1 in the body. Tirzepatide mimics the GIP pathway in addition to the GLP-1 pathway.
These medications help regulate blood sugar levels. They also slow down the rate at which food moves through the stomach, which can reduce appetite and promote weight loss.
They are typically administered as a once-weekly injection. The appropriate dose will depend on the patient’s individual needs.
They are not a substitute for a healthy diet and exercise, and should be used in conjunction with these lifestyle changes to achieve optimal results. As with any medication, it is important to talk to your healthcare provider about the potential benefits and risks of these medications and whether they are the right choice for you.
These medications are used to treat type 2 diabetes and obesity.
Type 2 diabetes: They are used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. They may be used alone or in combination with other diabetes medications.
Obesity: They are used as an adjunct to a reduced-calorie diet and increased physical activity to help promote weight loss in adults with a body mass index (BMI) of 30 or higher, or in adults with a BMI of 27 or higher who have at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol.
Semaglutide is not recommended for use in patients with type 1 diabetes or diabetic ketoacidosis. It is also not recommended for use in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, as semaglutide may increase the risk of these conditions.
As with any medication, they should only be prescribed by a healthcare provider who has evaluated the patient’s medical history, current health status, and individual needs and goals. Patients should follow their healthcare provider’s instructions for use and attend regular follow-up appointments to monitor progress and assess the need for continued treatment.
These medications can cause side effects in some patients. Some of the commonly reported side effects include:
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Abdominal pain
- Loss of appetite
- Headache
- Fatigue
- Dizziness
These side effects are usually mild to moderate in intensity and tend to improve over time as the body adjusts to the medication. However, if these side effects persist or become severe, patients should contact their healthcare provider for further evaluation and guidance.
In rare cases, they can cause more serious side effects such as:
- Pancreatitis (inflammation of the pancreas)
- Hypoglycemia (low blood sugar)
- Kidney problems
- Gallbladder problems
- Allergic reactions
Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, persistent nausea or vomiting, rapid heartbeat, difficulty breathing, or swelling of the face, lips, tongue, or throat.
Up to 15% with Semaglutide and up to 21% with Tirzepatide
Semaglutide and Tirzepatide are currently approved by the FDA for long-term use in the treatment of obesity.
Patients who stop the medication gain back on average two thirds of the weight they had lost. It is recommended that patients remain on a maintenance dose to curb cravings and maintain the new weight.
If your prior authorization is declined, your insurance will not cover the cost of the prescribed medication. In this instance, you have the option to self-fund your medication via our partnered pharmacies.
If you wish to share lab results, images, or any other relevant documents with your physician, you need to log into your Charm Tracker portal. Once there, select ‘Documents’ from the options and upload your documents.
The cost details of all our plans are clearly exhibited on our website. The flat-fee displayed for each plan is the total amount you’ll be required to pay each month or contact us today.